The fourth annual Parkinson's Disease Therapeutics conference, chaired by Franz Hefti, PhD - Scientific Advisory Board member of the Michael J. Fox Foundation for Parkinson's Research and Chief Scientific Officer of Avid Radiopharmaceuticals in Philadelphia, Pennsylvania - will highlight novel advances in basic and translational research that impact our understanding of Parkinson's Disease and its treatment. Select Michael J. Fox Foundation-funded investigators will present research on a variety of topics, including novel therapeutic targets, biomarkers for early detection and assessment of disease progression and strategies to alleviate symptoms and/or to slow disease progression. In addition, a small poster session on innovative PD targets and critical research tools will take place.